A real-life study of patients with severe asthma and EGPA treated with anti- IL5R

被引：0
|
作者：
Muemmler, C. [1 ]
Mertsch, P. [1 ]
Barnikel, M. [1 ]
Schoenermarck, U. [2 ]
Schulze-Koops, H. [2 ]
Behr, J. [1 ]
Kneidinger, N. [1 ]
Milger, K. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 5, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 4, Munich, Germany
来源：
PNEUMOLOGIE | 2023年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 337
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [21] A real-life comparison of patients with severe eosinophilic asthma treated with benralizumab or mepolizumab
    Andersen, Helle H.
    Smidt-Hansen, Torben
    Pedersen, Lene M.
    Skjold, Tina
    Schmid, Johannes
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [22] A comparison of the impact of anti-IL5/5r therapies in allergic versus non-allergic patients with severe eosinophilic asthma in a real-life setting
    Navarro-Cascales, Tatiana
    Colque-Bayona, Monica
    Fernandez-Concha, Ines
    Laorden, Daniel
    Quirce, Santiago
    Dominguez-Ortega, Javier
    JOURNAL OF ASTHMA, 2025, 62 (02) : 319 - 327
  • [23] Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data
    de Llano, Luis A. Perez
    Cosio, Borja G.
    Astiarraga, Ignacio Lobato
    Campos, Gregorio Soto
    Alonso, Miguel Angel Tejedor
    Malanda, Nuria Marina
    Galo, Alicia Padilla
    Landa, Isabel Urrutia
    de la Rosa, Francisco J. Michel
    Garcia-Moguel, Ismael
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 79 - 88
  • [24] Response to omalizumab in patients with severe allergic asthma: A real-life study
    Zierau, Louise
    Waisted, Emil Schwarz
    Thomsen, Simon Francis
    Backer, Vibeke
    RESPIRATORY MEDICINE, 2017, 131 : 109 - 113
  • [25] Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab in Real-Life Settings: The Prospective, REALITI-A Study
    Chaudhuri, R.
    Canonica, G. W.
    Bals, R.
    Lougheed, M. D.
    Pilette, C.
    Ramos-Barbon, D.
    Pollard, S.
    Maxwell, A.
    Worsley, S.
    Van Dyke, M. K.
    Joksaite, S.
    Howarth, P.
    Cristancho, R. Alfonso
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [26] Anti-IL-5 treatments in severe eosinophilic asthma: real life datas
    Ozdel Ozturk, Betul
    Bavbek, Sevim
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2020, 68 (02): : 148 - 159
  • [27] ANTI-IL-5-RECEPTOR TREATMENT IN SEVERE ASTHMA: REAL LIFE DATA
    Baptista, Mafalda
    Costa-Martins, Sara
    Barata, Juliana
    Rocha, Daniel Pimenta
    Craveiro, Ana Pedro
    Lopes, Ines Vicente
    Valente, Maria Beirao
    Valente, Maria
    CHEST, 2021, 160 (04) : 53A - 53A
  • [28] Long-Term Therapy Response to Anti-IL-5 Biologics in Severe Asthma-A Real-Life Evaluation
    Eger, Katrien
    Kroes, Johannes A.
    ten Brinke, Anneke
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1194 - 1200
  • [29] Predictor of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Numata, Takanori
    Miyagawa, Hanae
    Okuda, Keitaro
    Utsumi, Hirofumi
    Hashimoto, Mitsuo
    Minagawa, Shunsuke
    Ishikawa, Takeo
    Hara, Hiromichi
    Araya, Jun
    Kuwano, Kazuyoshi
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [30] Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
    Takanori Numata
    Hanae Miyagawa
    Saiko Nishioka
    Keitaro Okuda
    Hirofumi Utsumi
    Mitsuo Hashimoto
    Shunsuke Minagawa
    Takeo Ishikawa
    Hiromichi Hara
    Jun Araya
    Kazuyoshi Kuwano
    BMC Pulmonary Medicine, 20
12345